a case of dermatographism with ocrelizumab use in ms
Published 3 years ago • 798 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
3:33
study of real-world evidence in patients with pms and rms treated with ocrelizumab
-
2:14
safely switching from natalizumab to ocrelizumab in patients with ms at risk of pml
-
4:56
work productivity improves in patients with rrms treated with ocrelizumab
-
2:16
casting: ocrelizumab safety profile in rrms
-
3:53
natalizumab improves mental and social health in a real-world ms cohort
-
5:26
fingolimod and ocrelizumab prevent successful immune responses to covid-19 vaccination in ms
-
6:22
what is chronic urticaria and dermatographism
-
1:01
dermatographism - daily do's of dermatology
-
2:11
leukocyte telomere length and disability in ms
-
6:55
development of migratory dermatographism after moderna covid-19 booster vaccination - tripti nagar
-
2:35
current imaging techniques in predicting ms outcomes
-
1:41
markers of biological aging predict disability development in ms
-
1:16
exploring the protective nature of pregnancy in ms
-
0:38
dermographism
-
0:40
future of dermatopathology
-
16:03
dermatographism (cause & treatments)| q&a with dermatologist dr dray
-
2:20
detecting ms progression with a wearable multisensor device
-
2:16
dermatographism - writing on the skin